Carcinoma, Ductal, Breast

"Carcinoma, Ductal, Breast" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.

Descriptor ID	D018270
MeSH Number(s)	C04.557.470.200.025.232.500 C04.557.470.615.132.500 C04.588.180.390 C17.800.090.500.390
Concept/Terms	Carcinoma, Ductal, Breast Carcinoma, Ductal, Breast Carcinoma, Invasive Ductal, Breast Invasive Ductal Carcinoma, Breast Carcinoma, Infiltrating Duct Carcinomas, Infiltrating Duct Carcinoma, Mammary Ductal Carcinoma, Mammary Ductal Carcinomas, Mammary Ductal Mammary Ductal Carcinomas Mammary Ductal Carcinoma

Below are MeSH descriptors whose meaning is more general than "Carcinoma, Ductal, Breast".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Glandular and Epithelial [C04.557.470]
Carcinoma [C04.557.470.200]
Adenocarcinoma [C04.557.470.200.025]
Carcinoma, Ductal [C04.557.470.200.025.232]
Carcinoma, Ductal, Breast [C04.557.470.200.025.232.500]
Neoplasms, Ductal, Lobular, and Medullary [C04.557.470.615]
Carcinoma, Ductal [C04.557.470.615.132]
Carcinoma, Ductal, Breast [C04.557.470.615.132.500]
Neoplasms by Site [C04.588]
Breast Neoplasms [C04.588.180]
Carcinoma, Ductal, Breast [C04.588.180.390]
Skin and Connective Tissue Diseases [C17]
Skin Diseases [C17.800]
Breast Diseases [C17.800.090]
Breast Neoplasms [C17.800.090.500]
Carcinoma, Ductal, Breast [C17.800.090.500.390]

Below are MeSH descriptors whose meaning is related to "Carcinoma, Ductal, Breast".

Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Ductal, Breast".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Carcinoma, Ductal, Breast" by people in this website by year, and whether "Carcinoma, Ductal, Breast" was a major or minor topic of these publications.

Bar chart showing 22 publications over 14 distinct years, with a maximum of 3 publications in 2011 and 2018

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	1	0	1
2002	0	1	1
2003	1	0	1
2004	2	0	2
2006	1	0	1
2008	2	0	2
2011	2	1	3
2012	1	0	1
2013	1	0	1
2014	2	0	2
2015	1	0	1
2016	1	1	2
2018	2	1	3
2020	1	0	1

Below are the most recent publications written about "Carcinoma, Ductal, Breast" by people in Profiles.

Philipovskiy A, Dwivedi AK, Gamez R, McCallum R, Mukherjee D, Nahleh Z, Aguilera RJ, Gaur S. Association between tumor mutation profile and clinical outcomes among Hispanic Latina women with triple-negative breast cancer. PLoS One. 2020; 15(9):e0238262.

View in: PubMed
Poola I, Yue Q, Gillespie JW, Sullivan PS, Aguilar-Jakthong J, Rao J, Shaaban AM, Sauter ER, Ricci AJ. Breast Hyperplasias, Risk Signature, and Breast Cancer. Cancer Prev Res (Phila). 2019 07; 12(7):471-480.

View in: PubMed
Khan F, Ricks-Santi LJ, Zafar R, Kanaan Y, Naab T. Expression of p27 and c-Myc by immunohistochemistry in breast ductal cancers in African American women. Ann Diagn Pathol. 2018 Jun; 34:170-174.

View in: PubMed
Khan F, Esnakula A, Ricks-Santi LJ, Zafar R, Kanaan Y, Naab T. Loss of PTEN in high grade advanced stage triple negative breast ductal cancers in African American women. Pathol Res Pract. 2018 May; 214(5):673-678.

View in: PubMed
Naab TJ, Gautam A, Ricks-Santi L, Esnakula AK, Kanaan YM, DeWitty RL, Asgedom G, Makambi KH, Abawi M, Blancato JK. MYC amplification in subtypes of breast cancers in African American women. BMC Cancer. 2018 03 09; 18(1):274.

View in: PubMed
Seijo E, Lima D, Iriabho E, Almeida J, Monico J, Echeverri M, Gutierrez S, Flores I, Lee JH, Fisher K, Grizzle WE, Sica GL, Butler C, Hicks C, Meade CD, Sodeke SO, Moroz K, Coppola D, Munoz-Antonia T. Construction and Validation of a Multi-Institutional Tissue Microarray of Invasive Ductal Carcinoma From Racially and Ethnically Diverse Populations. Cancer Control. 2016 Oct; 23(4):383-389.

View in: PubMed
Kawprasertsri S, Pietras RJ, Marquez-Garban DC, Boonyaratanakornkit V. Progesterone receptor (PR) polyproline domain (PPD) mediates inhibition of epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer cells. Cancer Lett. 2016 May 01; 374(2):279-91.

View in: PubMed
Jones V, Linebarger J, Perez S, Gabram S, Okoli J, Bumpers H, Burns B, Mosunjac M, Rizzo M. Excising Additional Margins at Initial Breast-Conserving Surgery (BCS) Reduces the Need for Re-excision in a Predominantly African American Population: A Report of a Randomized Prospective Study in a Public Hospital. Ann Surg Oncol. 2016 Feb; 23(2):456-64.

View in: PubMed
Jones J, Wang H, Karanam B, Theodore S, Dean-Colomb W, Welch DR, Grizzle W, Yates C. Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas. Clin Exp Metastasis. 2014 Jun; 31(5):497-510.

View in: PubMed
Fu M, Maresh EL, Helguera GF, Kiyohara M, Qin Y, Ashki N, Daniels-Wells TR, Aziz N, Gordon LK, Braun J, Elshimali Y, Soslow RA, Penichet ML, Goodglick L, Wadehra M. Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancer. Mol Cancer Ther. 2014 Apr; 13(4):902-15.

View in: PubMed

People

Explore

Similar Concepts

Top Journals